Brexit Would Threaten Two Key Pillars of Health-Care Industry
- Drugs regulation and new unified patent system at risk
- 55 healthcare executives sign letter opposing exit from EU
Weighing the 'Brexit' Risk
This article is for subscribers only.
Britain leaving the European Union would threaten key pillars that underpin the health-care sector, one of the engines of the U.K. economy, a trade group warned in a letter endorsed by 55 industry executives.
London is home to the European Medicines Agency, the region’s regulatory body for drugs, and will also host a forthcoming court for pharmaceutical patents that would consolidate intellectual property across 25 countries. Both would likely need to move if Britons vote to leave the EU in a June 23 referendum.